BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting

  April 17, 2026

   · 

  5 min read
• Press Releases

  Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026

  April 17, 2026

   · 

  7 min read
• Press Releases

  Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC

  April 17, 2026

   · 

  2 min read
• Press Releases

  Conference Call on Interim Report January-March 2026

  April 17, 2026

   · 

  1 min read
• Press Releases

  Corify Care Receives FDA Clearance for ACORYS® -- Introducing Instant, 4-D Electroanatomical Cardiac Mapping in Real-time

  April 17, 2026

   · 

  3 min read
• Press Releases

  Ultima Genomics releases groundbreaking TRACERx MRD data showing ppmSeq performance and unveils clinical progress of whole genome sequencing at inaugural global MRD Symposium at AACR 2026

  April 17, 2026

   · 

  9 min read
• Press Releases

  Volastra Therapeutics Announces Biomarker and Combination Data around AACR 2026 Defining an Rb Pathway-Driven Pan-Cancer Development Strategy for KIF18A Inhibitors

  April 17, 2026

   · 

  4 min read
• Press Releases

  Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital

  April 17, 2026

   · 

  6 min read
• Press Releases

  Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified

  April 17, 2026

   · 

  4 min read
• Press Releases

  Marengo Reports Late-Breaking Initial Phase 2 Clinical Results from Invikafusp Alfa Plus TRODELVY® and Unveils Partnered Novel IPN01203/STAR0501 STAR Program in Phase 1 at AACR 2026

  April 17, 2026

   · 

  6 min read